FDA addresses interstate distribution of compounded drugs in new MOU Posted 18 May 2020 | By Kari Oakes

https://www.raps.org/news-and-articles/news-articles/2020/5/fda-addresses-interstate-distribution-of-compounde

05/19/2020

05/06/2020

IntegraDose Compounding Services LLC

Division of Pharmaceutical Quality Operations III

Compounding Pharmacy/Adulterated Drug Products

05/19/2020

05/07/2020

New Spirit Naturals Inc.

Division of Human and Animal Food Operations West V

New Drug/Misbranded

05/19/2020	05/11/2020	Health Cabin	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
05/19/2020	05/11/2020	Fullest Closet	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

05/18/2020

05/11/2020

Center for New Medicine/Perfectly Healthy by Connealy MD

Center for Food Safety and Applied Nutrition (CFSAN)

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

05/18/2020

05/15/2020

The Golden Road Kratom

Center for Drug Evaluation and Research | CDER

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

05/18/2020

05/15/2020

Noetic Nutraceuticals

Center for Drug Evaluation and Research | CDER

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

05/19/2020

05/05/2020

Blaine Labs Inc

Division of Pharmaceutical Quality Operations IV

CGMP/Finished Pharmaceuticals/Adulterated

05/19/2020

05/04/2020

Rajshree International, Inc.

Division of West Coast Imports

Foreign Supplier Verification Program (FSVP

05/19/2020

04/24/2020

International Trading Pharm Lab Inc

Division of Pharmaceutical Quality Operations I

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated